Evidence map›Paper›PMID 36064745›Full record

ArticleAddiction science & clinical practice2022

Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County.

Angela R Bazzi, Alicia Harvey-Vera, Tara Buesig-Stamos, Daniela Abramovitz, Carlos F Vera, Irina Artamonova, Thomas L Patterson, Steffanie A Strathdee

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Addiction science & clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05181657 (LinkUP), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05181657 nacompletednot on this map

LinkUP: COVID-19 Intervention for Underserved Populations Participating in Parent Study Proyecto La Frontera

TypeinterventionalSponsorUniversity of California, San DiegoRan2022 to 2024Enrolled150ConditionsMotivational InterviewingArmsCOVID-19 education
3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Angela R BazziHerbert Wertheim School of Public Health, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA, MC0631, USA.
Alicia Harvey-VeraSchool of Medicine, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA, MC0507, USA.
Tara Buesig-StamosOnPoint, Harm Reduction Coalition of San Diego, 1389 Windmill Road, El Cajon, CA, USA.
Daniela AbramovitzSchool of Medicine, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA, MC0507, USA.
Carlos F VeraSchool of Medicine, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA, MC0507, USA.
Irina ArtamonovaSchool of Medicine, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA, MC0507, USA.
Thomas L PattersonDepartment of Psychiatry, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA, MC0680, USA.
Steffanie A StrathdeeSchool of Medicine, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA, MC0507, USA. sstrathdee@health.ucsd.edu.ORCID 0000-0002-7724-691X

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Marketsand Drug TourismR01DA049644 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2020 to 2024
$8.2M
Preventing HIV infection among people who inject drugs during COVID-19K01DA043412 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAZZI, ANGELA ROBERTSON · 2017 to 2021
$934k
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIDA NIH HHS K01 DA043412NIDA NIH HHS R01 DA049644
6 · The paper itself

Abstract

backgroundPeople who inject drugs (PWID) have low rates of COVID-19 testing and vaccination and are vulnerable to severe disease. We partnered with a local, community-based syringe service program (SSP) in San Diego County, CA, to develop the single-session theory- and evidence-informed "LinkUP" intervention to increase COVID-19 testing and vaccination. This paper details the protocol for a pilot randomized controlled trial (RCT) of the LinkUP intervention.

methodsWith significant community input into study design considerations, including through our Community and Scientific Advisory Board, the LinkUP pilot RCT leverages an ongoing cohort study with adult (≥ 18 years) PWID in San Diego County to recruit participants who have not recently undergone voluntary COVID-19 testing and are unvaccinated. Eligible participants are referred to SSP locations randomized to offer the active intervention (involving tailored education, motivational interviewing, and problem-solving strategies) or a didactic attention-control condition (information sharing only). Both conditions are delivered by trained peer counselors hired by the SSP and were designed to be delivered at mobile (outdoor) SSP sites in ~ 30 min. Intake data assesses COVID-19 testing and vaccination history, health status, and harm reduction needs (to facilitate SSP referrals). At the end of either intervention condition, peer counselors offer onsite rapid COVID-19 antigen testing and COVID-19 vaccination referrals. Out-take and follow-up data (via SSP and state health department record linkages) confirms whether participants received the intervention, COVID-19 testing (and results) onsite or within six months, and vaccination referrals (and uptake) within six months. Planned analyses, which are not powered to assess efficacy, will provide adequate precision for effect size estimates for primary (COVID-19 testing) and secondary (vaccination) intervention outcomes. Findings will be disseminated widely including to local health authorities, collaborating agencies, and community members. DISCUSSION: Lessons from this community-based pilot study include the importance of gathering community input into study design, cultivating research-community partnerships based on mutual respect and trust, and maintaining frequent communication regarding unexpected events (e.g., police sweeps, neighborhood opposition). Findings may support the adoption of COVID-19 testing and vaccination initiatives implemented through SSPs and other community-based organizations serving vulnerable populations of people impacted by substance use and addiction. Trial registration This trial was registered prospectively at ClinicalTrials.gov (identifier NCT05181657).

Indexed as

COVID-19Drug UsersSubstance Abuse, IntravenousAdultCOVID-19 TestingHumansPilot ProjectsRandomized Controlled Trials as TopicSARS-CoV-2VaccinationCOVID-19 testingHarm reductionIntravenousMotivational interviewingSARS-CoV-2Substance useVaccinationVulnerable populations

Identifiers

PMID36064745
PMCPMC9444113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.